Navigation Links
Surefire Medical Launches Next Generation Infusion System ST-LT and Specialty Catheters at SIR - Maximizing Targeted Delivery of Embolics Without Reflux
Date:4/13/2013

New Orleans, LA (PRWEB) April 13, 2013

Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced the launch of the company’s next-generation Surefire Infusion System and Specialty Catheters at the Society of Interventional Radiology (SIR) 38th Annual Meeting, held in New Orleans April 13-18. The new ST and LT microcatheters can accommodate smaller vessels and selective procedures in direct-to-tumor cancer treatment.

Now available in the U.S., Europe, Canada and New Zealand, the company’s new Surefire Infusion System--ST and Surefire Infusion System--LT microcatheters for the interventional radiology and interventional oncology markets are distinguished by their expandable tip. When deployed, the tip expands dynamically to the walls of the artery, preventing any damage caused by backflow into healthy, non-target vessels and tissues.

“The new Surefire Infusion System makes some treatment dilemmas far less problematic, and thus may improve patient safety. However, the far more exciting aspect of the new system is the potential for improving the efficacy of therapy, said Fred Moeslein, M.D., Interim Director, Division of Vascular and Interventional Radiology, University of Maryland School of Medicine.

“Currently, Drug-Eluting Bead Chemoembolization (DEB-TACE) is performed routinely across this country and around the globe using end-hole catheters. Often, especially in the setting of hypovascular tumors or heavily pretreated tumors, stasis is reached early, thus limiting drug delivery. The Surefire system allows us to deliver more drug to the tumor, even in the setting of stasis without risk of reflux or non-target embolization. Therefore the new system gives us the capability to control drug delivery far better than with a standard end-hole catheter.”

In addition, newly published data in
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AtheroNova Adds New Medical Advisor
2. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
3. “Scientific And Medical Research On The Successful Treatment Of Type 1 + 2 Diabetes With Alkaline Reduced Water” is Reviewed in Today’s Bawell Water Ionizer Health Report
4. Dermatology Associates Medical Group in Beverly Hills Announces Safe, Fast Anti-Aging Laser Treatment
5. ICMs New Blue Gene Supercomputer Supports The Largest Biomedical Research Initiative In Poland
6. Medical Marijuana Inc., Corporate Update- Significant Revenue and Net Income Growth 1st Quarter- Division and Corporate Holdings Update
7. First Warning Systems, Inc., Appoints Veteran Medical Executive Royea as CEO
8. Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst
9. Medical University of South Carolina Selects Elseviers Interdisciplinary Care Planning and Clinical Documentation Solution
10. Final Week of IpAuctions, Inc. All Things Medical Auction Event
11. Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... April 27, 2015  Together with its customers, Elekta ... Forum in Barcelona . The funds ... with the mission to improve cancer care, specifically radiation ... believes that no patient should be denied potentially life-saving ... it cooperates with hospitals and clinics around the world ...
(Date:4/24/2015)... California (PRWEB) April 24, 2015 ... key milestones in its allogeneic stem-cell product development ... to properly reflect the corporate strategic direction. , ... allogeneic (donor) adipose stem cell development program has ... of our cGMP manufacturing facility and hiring of ...
(Date:4/24/2015)... N.J. , April 24, 2015  Navitas Life Sciences ... as Head of Clinical and Regulatory Services. Shalabh is ... been a co-founder and CEO of Kinapse, as well as ... Logo - http://photos.prnewswire.com/prnh/20150423/201261LOGO ... Jim Tizzard commented "I am delighted to welcome Shalabh ...
(Date:4/23/2015)... 23, 2015 The Thomas Brain ... conduct a groundbreaking pilot study to see if ... in as little as three to six months. ... and nutritional medicine—will aggressively target and simultaneously treat ... our aging brain. These include oxidative stress, neuroinflammation, ...
Breaking Biology Technology:Elekta helps raise $33,000 to bring radiation treatment to developing countries 2Elekta helps raise $33,000 to bring radiation treatment to developing countries 3Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma 2Shalabh Kumar Joins Navitas Life Sciences to Lead their Clinical and Regulatory Services Teams 2New Study Looks to Reverse Alzheimer’s Disease 2New Study Looks to Reverse Alzheimer’s Disease 3
... YORK, Aug. 10 ExL Pharma is pleased ... many of the leading issues that are,impacting the ... offer educational and networking opportunities for Clinical,Marketing, R&D, ... biotech and medical technology companies. Listed below ...
... Genmab,s Partner Roche has Filed an IND With the US FDA for ... ... A/S (OMX: GEN),announced today that its partner Roche has filed an Investigational ... antibody developed under the companies, collaboration. Genmab will,receive a milestone payment from ...
... Reliant Pharmaceuticals,Inc. today announced that it has filed ... Exchange Commission for an initial public offering,of its common ... issued common stock and that certain stockholders may sell,a ... Goldman, Sachs & Co. and Merrill Lynch & ...
Cached Biology Technology:Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharma's Fall Line Up! 2Roche Files IND for Second Genmab Antibody 2Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering 2
(Date:4/1/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces the second shipment of a ... early access pre-order customers. Feedback from ... including Walmart, Target, AT&T, Dunkin, Donuts, Stop & Shop ... all outlets and very easy to use. Several users ...
(Date:3/31/2015)... March 31, 2015  Elephant Talk Communications Corp. (NYSE ... provider of Software Defined Network Architecture (ET Software DNA® ... revenue of approximately $20.4 million for the year ended ... million for the year ended December 31, 2013. ... Company had completed its multi-year transition away from its ...
(Date:3/30/2015)... and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has announced ... in Automotive Sector 2014-2018" report to their offering. ... market in Automotive Sector to grow at a CAGR ... recognition is the ability of a device to identify ... recognition technology can be 2D-based or 3D-based. It uses ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... as a folk remedy, but now scientists from Britain and ... as a treatment for herpes. The team,s findings, published in ... between two teams to established scientific evidence for traditional medicines. ... across mainland Europe and Asia. From the Middle Ages onwards ...
... OAK RIDGE, Tenn, Feb. 22, 2011 -- A theoretical ... National Laboratory is bringing supercomputer simulations and experimental results ... ORNL,s Jeremy Smith collaborated on devising a method -- ... experiments and computer simulations to strengthen analyses of molecules ...
... Conservation Society (WCS) working in conjunction with the Turtle ... from around the world some of which currently ... hunting for both food and the pet trade along ... in the next decade unless drastic conservation measures are ...
Cached Biology News:Old folk remedy revived: How tansy may be a treatment for herpes 2'Fingerprints' match molecular simulations with reality 2Shellshock: New report lists 25 most endangered turtle species 2
COMING SOON: Anti-Mouse C5/C5b, Clone BB5.1. Monoclonal Antibody...
... Goat anti-Human Alpha 1 Acid ... azide Goats were immunized ... glycoprotein in Freund's adjuvant. ... absorbed to ensure specificity. ...
Anti-Mouse Valpha 2 TCR, Purified (Clone B20.1) (rat IgG2a)...
Request Info...
Biology Products: